Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Aegera Therapeutics Inc.

Headquarters: Montreal, QC, Canada
Website: N/A
Year Founded: 1996
Status: Acquired

BioCentury | Nov 11, 2013
Company News

Bioniche management update

BioCentury | Dec 17, 2012
Company News

Pharmascience, GlaxoSmithKline deal

BioCentury | Jan 16, 2012
Clinical News

HGS1029: Development halted

BioCentury | Jan 16, 2012
Company News

Human Genome Sciences autoimmune, cancer news

BioCentury | Jun 6, 2011
Company News

Aegera, Pharmascience deal

BioCentury | Sep 20, 2010
Emerging Company Profile

Calithera: Activating Caspases

Calithera's caspase activators may be highly selective for specific cancers
BioCentury | Feb 1, 2010
Clinical News

AEG35156: Phase II started

BioCentury | Dec 7, 2009
Clinical News

AEG35156: Phase IIb started

BioCentury | Dec 7, 2009
Clinical News

HGS1029: Phase I started

BioCentury | Sep 28, 2009
Financial News

Aegera completes venture financing

Items per page:
1 - 10 of 44